SEARCH RESULTS FOR: "Tag: LLY"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(2)
ARTICLES/BLOGS
2023(2)
2022(5)
2021(7)
2020(18)
2019(7)
2018(6)
2017(7)
2016(11)
2015(16)
2014(1)
CATEGORIES
5-Minute Market Rundown(5)
Analyst Downgrades(2)
Analyst Update(6)
Analyst Upgrades(6)
Best and Worst Stocks(3)
Buzz Stocks(19)
By the Numbers(3)
Earnings Preview(1)
Editor's Pick(1)
Expectational Analysis(1)
Ezines(3)
General(2)
Indicator of the Week(1)
Intraday Option Activity(7)
Market Recap(3)
Midday Market Check(2)
Opening View(14)
Podcast(1)
Quantitative Analysis(4)
Stock Market News(2)
Stocks On the Move(3)
Strategies and Concepts(1)
The Week Ahead(3)
Trade Postmortem(1)
Trader Content (1)

1/20/2023 11:15 AM
The U.S. Food and Drug Administration (FDA) rejected the accelerated approval of Eli Lilly and Co's (NYSE:LLY) experimental Alzheimer's drug due to a lack of enough trial data from patients treated f...
1/11/2023 1:04 PM
According to BMO, near-term hurdles such as competition for key drugs and patent expiries won't derail the long-term revenue and earnings growth of Eli Lilly And Co (NYSE:LLY). While the drugmaker fo...
10/27/2022 10:46 AM
Halloween falls on a Monday this year, marking the end of a wild October and the start of a jam-packed month for markets. While spooky season might be coming to a close, investors can expect a few tre...
9/23/2022 12:48 PM
While the central bank has been anything but shy about its hawkish intentions, investors seem convinced that the aggressive rate hikes are putting the economy on track for a recession. As such, purs...
9/22/2022 10:03 AM
Eli Lilly and Co (NYSE:LLY) is getting a boost today, after news that the U.S. Food & Drug Administration (FDA) approved its cancer drug Retevmo for new uses, including treatment of patients with a su...